Why is Mono Pharmacare falling/rising?

As of 03-Jul, Mono Pharmacare Ltd's stock price is currently at 25.65, showing no change (0.00%). The stock has underperformed its sector by 0.48% today, despite being higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains lower than the 200-day moving average. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 28.57% compared to the 5-day average. Over the past week, the stock has gained 4.69%, while its performance over the last month shows a modest increase of 0.59%. However, the year-to-date return is significantly negative at -25.97%, and the one-year return stands at -35.88%, indicating a longer-term downward trend.
In the broader market context, the Sensex has experienced a slight decline of 0.56% over the past week, while Mono Pharmacare's recent performance has been more favorable in comparison. Despite this short-term outperformance, the stock's year-to-date and one-year returns are considerably worse than the Sensex, which has gained 7.45% and 4.61%, respectively. This suggests that while there may be some short-term recovery, the overall market sentiment and the stock's long-term performance remain weak, contributing to the challenges faced by Mono Pharmacare in attracting sustained investor interest.